Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-21-008935
Filing Date
2021-09-24
Accepted
2021-09-24 19:36:42
Documents
1
Period of Report
2021-09-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 25517
  Complete submission text file 0001179110-21-008935.txt   26865
Mailing Address C/O ACCELERON PHARMA INC. 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
MCLAUGHLIN KEVIN F (Reporting) CIK: 0001214938 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36065 | Film No.: 211278623

Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Issuer) CIK: 0001280600 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)